SCHEMBL5230508

SCHEMBL5230508

Cc1ncc(C=S)c(Nc2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.42
KDR P35968 2/20 0.42
IGF1R P08069 2/20 0.41
ITK Q08881 2/20 0.41
JAK2 O60674 2/20 0.41
SYK P43405 2/20 0.41
PLK4 O00444 1/20 0.41
AURKA O14965 1/20 0.41
PDPK1 O15530 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
NTRK1 P04629 1/20 0.41
INSR P06213 1/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
CDK1 P06493 1/20 0.41
FES P07332 1/20 0.41
CSF1R P07333 1/20 0.41
LYN P07948 1/20 0.41
ROS1 P08922 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6336909 0.84 AURKA (0.45) EGFRKDRAURKACLK4STK17A
SCHEMBL859187 0.80 EGFR (0.51) EGFRKDRIGF1RITKJAK2
SCHEMBL7850447 0.76 SYK (0.41) EGFRITKSYKBTKMAPK1
SCHEMBL3533350 0.75 IKBKB (0.30)
SCHEMBL4829937 0.71 PDK2 (0.36) KDM4E
SCHEMBL7714549 0.71 AURKA (0.41) EGFRKDRIGF1RITKJAK2
SCHEMBL5228294 0.70 KDM4E (0.43) SYKMAPK8MAPK1KDM4EHTT
SCHEMBL4186011 0.69 GABBR2 (0.43) IRAK4MAPK1CYP3A4CYP2D6KMT2A
SCHEMBL13949307 0.68 JAK2 (0.47) EGFRJAK2AURKANTRK1CDK2
SCHEMBL4770475 0.66 PDK2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1228070-B1 HETEROALKYLAMINO-SUBSTITUTED BICYCLIC NITROGEN HETEROCYCLES AS INHIBITORS OF P38 PROTEIN KINASE HOFFMANN LA ROCHE (CH) 2007-02-07 EP disclosed
EP-1123295-B1 BICYCLIC NITROGEN HETEROCYCLES HOFFMANN LA ROCHE (CH) 2004-09-29 EP disclosed
US-6451804-B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles SYNTEX (U.S.A.) LLC 2002-09-17 US disclosed
EP-1228070-A1 HETEROALKYLAMINO-SUBSTITUTED BICYCLIC NITROGEN HETEROCYCLES AS INHIBITORS OF P38 PROTEIN KINASE F. HOFFMANN-LA ROCHE AG (CH) 2002-08-07 EP disclosed
EP-1123295-A1 BICYCLIC NITROGEN HETEROCYCLES F. HOFFMANN-LA ROCHE AG (CH) 2001-08-16 EP disclosed
WO-2001029042-A1 HETEROALKYLAMINO-SUBSTITUTED BICYCLIC NITROGEN HETEROCYCLES AS INHIBITORS OF P38 PROTEIN KINASE F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed
US-6150373-A AMINO-SUBSTITUTED DIHYDROPYRIMIDO(4,5-D)PYRIMIDINONE DERIVATIVES; INHIBITORS OF THE T-CELL TYROSINE KINASE P56LCK; IMMUNOSUPPRESSANTS; ANTIINFLAMMATORY/-CARCINOGENIC AGENTS; BRONCHOPULMONARY, DERMATOLOGICAL AND CARDIOVASCULAR DISORDERS HOFFMANN-LA ROCHE INC. (US) 2000-11-21 US disclosed
WO-2000024744-A1 BICYCLIC NITROGEN HETEROCYCLES F. HOFFMANN-LA ROCHE AG (CH) 2000-05-04 WO disclosed